✦ LIBER ✦

The evolution of lung cancer screening

✍ Scribed by Neal W. Wilkinson; Gregory M. Loewen; Donald L. Klippenstein; Alan M. Litwin; Timothy M. Anderson

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 140 KB
Volume: 84
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.10315

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Screening for lung cancer

✍ Edward J. Beattie; James C. Harvey 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Surgical considerations with lung cancer

Surgical considerations with lung cancer screening

✍ Elizabeth E. Warner; James L. Mulshine 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Screening for lung cancer in the middle-

Screening for lung cancer in the middle-aged

✍ R. Berndt; P. Nischan; K. Ebeling 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 211 KB 👁 1 views

A screening programme for lung diseases has been in operation in the German Democratic Republic for more than 3 decades. The programme is based on biennial chest X-rays (70 X 70 mm posterior-anterior) of the population 40 years of age or over. With respect to lung cancer the results show that, for t

Cost-effectiveness of lung cancer screen

Cost-effectiveness of lung cancer screening in Japan

✍ Naoyuki Okamoto 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB 👁 3 views

## BACKGROUND. Because the mortality rate from lung cancer is increasing sharply in Japan, lung cancer screening is being performed actively to assure early diagnosis and early treatment. However, its effectiveness is not clear, because it is extremely difficult to diagnose early microcarcinoma of

Healthcare use after screening for lung

Healthcare use after screening for lung cancer

✍ Margaret M. Byrne; Tulay Koru-Sengul; Wei Zhao; Joel L. Weissfeld; Mark S. Rober 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB

## Abstract ## BACKGROUND: To evaluate the benefits of lung cancer screening, all effects of screening need to be considered. The aim of this study was to determine whether screening had an effect on healthcare use, specifically whether use increased for those with a false‐positive or indeterminat

The prostate, lung, colorectal, and ovar

The prostate, lung, colorectal, and ovarian cancer screening trial of the national cancer institute

✍ John K. Gohagan; Philip C. Prorok; Barnett S. Kramer; Richard B. Hayes; Joyce E. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 2 views

The two-year pilot phase of the Prostate, Lung, Colorectal, and Ovarian (PLCO) trial concluded September 29, 1994. The goals, organization, operation, and recruitment status of the trial are discussed. The PLCO trial is a 16year randomized controlled screening trial involving 148,000 male and female